/* Product view custom css */
Gynofem Healthcare & Pharmaceuticals Ltd unlisted shares

Gynofem Healthcare & Pharmaceuticals Ltd Unlisted shares

Master

Gynofem Healthcare & Pharmaceuticals Ltd Unlisted shares

Face Value 1
ISIN No INE0NLL01017

You Can Buy The Below Quantity From Us By Clicking On “Buy Now” Or For More & Bulk Quantity, You Can Contact Us On: 02249369990 / 09867572101 / 09987204585
ID Face Value Quantity Rate Amount Mode Minimum Lot Size  
1011856 1 1000 Rs 58.00 Rs 58,000.00 Rs Demat 500

Company Information

Gynofem Healthcare and Pharmaceuticals Limited Unlisted Shares


Board of Directors

Directors

: Nishi Kant Joshi, Anurag Mendhe


Background

Gynofem Healthcare and Pharmaceuticals Ltd is an Indian pharmaceutical company engaged in the development, marketing, and distribution of pharmaceutical formulations for women's healthcare, including fertility treatment, pregnancy care, and hormonal disorders.


Registered Office

13/12 Pipliya Kumar, Amorb House, near Eicher Work Shop, Vijay Nagar, Indore, Indore, Madhya Pradesh, India, 452010.


INCORPORATION YEAR

: 2022

WEBSITE

: www.gynofemhealthcare.com

EMAIL

: gynofempharmaltd@gmail.com

CIN NO

: U24290MP2022PLC063077

ISIN NO.

: INE0NLL01017

SECTOR

: Healthcare and Pharmaceutical

FACE VALUE

: 1

PROMOTER HOLDING

: 79.84%


Financial Information for Last 3 Years (Rupees In Crore)

Particulars

2025

2024

2023

Equity Capital

9.92

9.92

9.92

Reserve & Surplus

(3.53)

(1.44)

(0.52)

Net worth

6.39

8.48

9.40

Book Value Per share Rs.

0.64

0.85

0.95

Total Income

4.94

4.37

1.34

Profit/ (Net Loss)

(2.09)

(0.92)

(0.52)

EPS Rs.

(0.21)

(0.09)

(0.05)


Annual Report of Gynofem Healthcare and Pharmaceuticals Limited Unlisted Shares


Annual Report of Gynofem Healthcare and Pharmaceuticals Limited – 2025

Financial Statement of Gynofem Healthcare and Pharmaceuticals Limited – 2024

Cookie Consent

We use cookies to ensure you have the best browsing experience on our website. By using our site, you acknowledge that you have read and understood our Cookie Policy & Privacy